AccurKardia develops automated clinical-grade ECG interpretation software for cardiac monitoring companies to expand access to remote cardiac care. Its platform combines proprietary AI and non-AI techniques to provide near-real-time ECG analytics in the cloud, on device, and at the edge. The company is pursuing R&D and clinical validation and plans to enable interaction with clinical and consumer wearables to scale tech-enabled healthcare. Since March 2023 AccurKardia has participated in Cohort 3 of Mayo Clinic Platform_Accelerate, leveraging de-identified datasets, validation frameworks, clinical workflow planning, and mentorship to accelerate its work. AccurKardia announced the final closing of a $2.7 million seed funding round to support validation and go-to-market efforts. The business is led by CEO Juan C. Jiménez with Co-founder, CPO & CTO Sadeq Ali.

Total raised

$3M

Funding rounds

1

Latest round

Seed

Latest activity

Jun 2023